Pharming (PHAR) Operating Income (2020 - 2025)
Historic Operating Income for Pharming (PHAR) over the last 6 years, with Q3 2025 value amounting to $22.9 million.
- Pharming's Operating Income rose 45664.56% to $22.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.0 million, marking a year-over-year increase of 12972.94%. This contributed to the annual value of -$8.6 million for FY2024, which is 6003.34% down from last year.
- Latest data reveals that Pharming reported Operating Income of $22.9 million as of Q3 2025, which was up 45664.56% from $3.8 million recorded in Q2 2025.
- Pharming's Operating Income's 5-year high stood at $6.3 billion during Q1 2021, with a 5-year trough of -$6.2 billion in Q2 2021.
- In the last 5 years, Pharming's Operating Income had a median value of -$1.7 million in 2021 and averaged $1.5 million.
- Examining YoY changes over the last 5 years, Pharming's Operating Income showed a top increase of 56480.42% in 2022 and a maximum decrease of 15930.23% in 2022.
- Pharming's Operating Income (Quarter) stood at $17.2 million in 2021, then tumbled by 159.3% to -$10.2 million in 2022, then skyrocketed by 47.19% to -$5.4 million in 2023, then crashed by 60.03% to -$8.6 million in 2024, then soared by 365.25% to $22.9 million in 2025.
- Its Operating Income stands at $22.9 million for Q3 2025, versus $3.8 million for Q2 2025 and -$7.0 million for Q1 2025.